• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconBayer

Bayer

0
Photo of Bill Anderson
HealthBayer CEO compares the state of troubled pharma group to the time he fractured his leg skateboarding: ‘We’re badly broken in 4 places’
By Ryan HoggMarch 6, 2024
Bill Anderson, chief executive officer of Bayer AG
FinanceBayer had its worst day ever as shares sunk to the lowest in over a decade on $1.5bn Roundup verdict and drug failure
By Tim Loh and BloombergNovember 20, 2023
Roundup
Health57-year-old man wins $332 million verdict against Monsanto on claim that Roundup weedkiller gave him incurable cancer
By The Associated PressNovember 3, 2023
FinanceBayer hit with $332 million judgement in trial of man who blames his cancer on decades using Monsanto’s Roundup weedkiller
By The Associated PressNovember 3, 2023
Sudafed
HealthThe top decongestant on the market doesn’t actually decongest, FDA says
By Matthew Perrone and The Associated PressSeptember 12, 2023
NewslettersShareholders are forcing Bayer’s CEO out. What do they expect from his replacement?
By Eamon BarrettMarch 10, 2023
FinanceThe world’s 10 biggest pharmaceutical companies raked in over $700 billion in revenue in 2021
By Paige McGlauflinAugust 15, 2022
NewslettersThe ‘everything rally’ continues: Bitcoin, ether at all-time highs while stocks go for 9-straight
By Bernhard WarnerNovember 9, 2021
In this photo illustration the Covax Facility logo seen displayed on a smartphone screen with the logo of CureVac in the background.
HealthCureVac scraps its first-generation COVID-19 vaccine candidate, shares tumble
By David MeyerOctober 12, 2021
An employee checks bottles of diluent inside the pharmaceutical plant Fareva in Poce-sur-Cisse, Central France, on April 22, 2021. Fareva was chosen as the main supplier of the candidate RNA messenger vaccine from the German company CureVac. The site will therefore produce the diluent used in this vaccine.
HealthThese four COVID-19 vaccines could soon join the pandemic fight
By David MeyerMay 8, 2021
An illustrative image of medical syringes in front of CureVac and Bayer logos displayed on a screen.
HealthAs alarm grows over Europe’s dwindling vaccine supplies, Bayer could offer its factories to the cause
By David MeyerJanuary 18, 2021
The logo of the biopharmaceutical company CureVac, is displayed in front of the company's headquarters in Tuebingen, southern Germany on December 15, 2020.
HealthBayer strikes deal to aid CureVac in its COVID-19 vaccine rollout
By David MeyerJanuary 7, 2021
NewslettersThe dollar, Bitcoin soar as the markets contend with a dreaded, contested election
By Bernhard WarnerNovember 4, 2020
Roundup weed killer that is the subject of thousands of lawsuits in the US, is pictured on sale in Los Angeles, California on September 1, 2019.
FinanceBayer could settle the Roundup cancer litigation, but the drama is far from over
By David MeyerJune 25, 2020
Bayer agrees to pay $12 billion in legal settlements, in effort to put Roundup scandal behind it
By Jef Feeley, Tim Loh and BloombergJune 25, 2020
0
Most Popular
Magazine
The youngest-ever female CEO of a Fortune 500 company is fighting Trump's cuts to keep Medicaid strongAn image of a popular article
By Fortune EditorsMarch 24, 2026
Commentary
The Treasury just declared the U.S. insolvent. The media missed itAn image of a popular article
By Fortune EditorsMarch 23, 2026
Success
Palantir’s billionaire CEO says only two kinds of people will succeed in the AI era: trade workers — ‘or you’re neurodivergent’An image of a popular article
By Fortune EditorsMarch 24, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.